The company anticipates sales of $313.6 million, up 7.9 percent from last year’s $290.5 million in net sales. Preliminary fourth quarter sales for the company’s surgical implants business grew 22.2 percent over the fourth quarter of 2012.
More Articles on Devices:
Device Companies — 6 Key Notes — NuVasive, Aurora Spine & More
Titan Spine Gains 5 Patents for Endoskeleton Interbody Devices
Budgetary Fund Could Pay to Eliminate Medical Device Tax
